Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
The jaguars.com 2026 free agent tracker, looking at free agents the Jaguars have acquired in 2026 and 2025 Jaguars players scheduled to become who became free agents on Wednesday, March 11 ...